BULLISHWHALES
BullishWhales · Congress · Issuer Profile
NASDAQ: RLAYRelay Therapeutics Inc
HealthcareMkt Cap $3.06BCongress ownership rank #3814

Relay Therapeutics Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 1 trade in Relay Therapeutics Inc (NASDAQ: RLAY) since 2023, across 1 member, worth an estimated $8.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). Democratic members are responsible for 100% of the trades and Republican members 0%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Relay Therapeutics Inc (RLAY) stock overview and the complete trade table below.

Trades
0
Politicians
0
Filings
0
Disclosed Vol
$0.00
Buys
0
Sells
0

Price & congressional trade timeline

Party breakdown

Relay Therapeutics congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturn
No congressional trades in this period.
Go to

Relay Therapeutics (RLAY) congressional trading FAQ

Can members of Congress legally trade Relay Therapeutics (RLAY) stock?

Yes. Members of Congress are permitted to trade individual stocks, including Relay Therapeutics (RLAY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.

Are congressional Relay Therapeutics (RLAY) trades public?

Yes. Every congressional trade in Relay Therapeutics (RLAY) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded Relay Therapeutics (RLAY)?

Members of Congress have disclosed 1 trades in Relay Therapeutics (RLAY) worth $8.00K across 1 members, according to public STOCK Act filings.

Do Democrats or Republicans trade Relay Therapeutics (RLAY) more?

Across disclosed Relay Therapeutics (RLAY) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).

Browse all stocks Congress tradesCongressional trading overviewRelay Therapeutics (RLAY) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30